Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Celecoxib, Irinotecan and Concurrent Radiotherapy in the Preoperative Treatment of Pancreatic Cancer

NCT00177853 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00177853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00177853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Celecoxib, Irinotecan and Concurrent Radiotherapy in the Preoperative Treatment of Pancreatic Cancer
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2006
Completion date
July 31, 2010
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer